S100A8/A9 is produced and secreted by multiple cell types in the tumor microenvironment (TME), including cancer cells and immune cells of the myeloid lineage, such as neutrophils, myeloid-derived suppressor cells (MDSCs), and tumor-associated macrophages (TAMs)7,11–13. This evidence concerns the gene IGKV1D-22 and neoplasm.